Search

Search Constraints

You searched for: Author/Creator Di Mario, F.

Search Results

21. P.01.24 GASTRIC FUNCTION MARKERS: BECAUSE ANTIBODIES ARE NOT ENOUGH IN THE EVALUATION OF AUTOIMMUNE GASTRITIS. (25th March 2019)

22. P.01.25 CAN A NON-INVASIVE TEST PREDICT THE RESULTS OF PH-IMPEDANCE? PROSPECTIVE STUDY OF A COHORT OF PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD. (25th March 2019)

23. P.01.25 THE RELATIONSHIP BETWEEN CHRONIC ATROPHIC GASTRITIS AND VITAMIN B12 AND FERRITIN SERUM LEVELS: A CLINICAL STUDY ON FUNCTIONAL ATROPHY. Issue 2 (15th March 2018)

24. P.01.29 GASTRIC ULCER: RISK FACTORS, HELICOBACTER PYLORI INFECTION AND NSAIDS USE IN A SAMPLE OF 256 PEOPLE. Issue 2 (15th March 2018)

25. P.01.30 THE USE OF PROTON-PUMP INHIBITORS (PPI) REDUCES THE FREQUENCY OF ENDOSCOPICALLY SIGNIFICANT LESIONS (ESL) IN ALL-CAUSE UPPER GASTROINTESTINAL ENDOSCOPY. Issue 2 (15th March 2018)

26. P.01.31 A COMPARISON OF DIFFERENT TREATMENTS FOR SYMPTOMATIC REFLUX ESOPHAGITIS: A REAL-LIFE STUDY. (25th March 2019)

27. P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients. (15th March 2017)

28. P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients. (15th March 2017)

29. P.01.8: Gerd Risk Factors in Different Epidemiological Settings: Results from a Structured Questionnaire on a Sample of 545 People. (15th March 2017)

30. P.02.10: Bismuth-Containing Quadruple Therapy in Patients Infected by Helicobacter Pylori: A First Real Life Italian Experience. (15th March 2017)